Risk assessment of arrhythmias related to three antiseizure medications: a systematic review and single-arm meta-analysis. | 2024 | Frontiers in Neurology |
The efficacy and safety of third-generation antiseizure medications and non-invasive brain stimulation to treat refractory epilepsy: a systematic review and network meta-analysis study. | 2024 | Frontiers in Neurology |
Antiseizure medications for idiopathic generalized epilepsies: a systematic review and network meta-analysis. | 2023 | Journal of Neurology |
Perampanel add‐on for drug‐resistant focal epilepsy. | 2023 | Cochrane Database of Systematic Reviews |
Efficacy and tolerability of perampanel in patients with seizures in real-world clinical practice: a systematic review and meta-analysis. | 2023 | Frontiers in Pharmacology |
Efficacy and tolerability of perampanel in brain tumor-related epilepsy: a systematic review. | 2023 | Biomedicines |
Efficacy, tolerability and safety of perampanel in children and adolescents with epilepsy: systematic review and meta-analysis. | 2023 | Brain & Development |
Perampanel in brain tumor-related epilepsy: a systematic review. | 2023 | Brain Sciences |
The safety of perampanel in different disorders and doses: a meta-analysis. | 2023 | Seizure: European Journal of Epilepsy |
Efficacy and safety of perampanel for epilepsy: a systematic review and meta-analysis of real-world studies. | 2023 | European Review for Medical and Pharmacological Sciences |
The efficacy and safety of adjunctive perampanel for the treatment of refractory focal-onset seizures in patients with epilepsy: a meta-analysis. | 2022 | Epilepsia Open |
Movement disorders secondary to novel antiseizure medications in pediatric populations: a systematic review and meta-analysis of risk. | 2022 | Journal of Child Neurology |
Third‑generation antiseizure medications for adjunctive treatment of focal‑onset seizures in adults: a systematic review and network meta‑analysis. | 2022 | Drugs |
Perampanel in achieving status epilepticus cessation: a systematic review. | 2022 | Epilepsy & Behavior |
Perampanel monotherapy for the treatment of epilepsy: Clinical trial and real-world evidence | 2022 | Epilepsy & Behavior |
Exploring the evidence for broad‑spectrum effectiveness of perampanel: a systematic review of clinical data in generalised seizures. | 2021 | CNS Drugs |
Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: a systematic review. | 2021 | Epilepsy & Behavior |
A systematic review and indirect treatment comparison of perampanel versus brivaracetam as adjunctive therapy in patients with focal-onset seizures with or without secondary generalization. | 2020 | Epilepsy Research |